Ocular Neurodegenerative Diseases: Interconnection between Retina and Cortical Areas

Abstract

The possible interconnection between the eye and central nervous system (CNS) has been a topic of discussion for several years just based on fact that the eye is properly considered an extension of the brain. Both organs consist of neurons and derived from a neural tube. The visual process involves photoreceptors that receive light stimulus from the external environment and send it to retinal ganglionic cells (RGC), one of the cell types of which the retina is composed. The retina, the internal visual membrane of the eye, processes the visual stimuli in electric stimuli to transfer it to the brain, through the optic nerve. Retinal chronic progressive neurodegeneration, which may occur among the elderly, can lead to different disorders of the eye such as glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy (DR). Mainly in the elderly population, but also among younger people, such ocular pathologies are the cause of irreversible blindness or impaired, reduced vision. Typical neurodegenerative diseases of the CSN are a group of pathologies with common characteristics and etiology not fully understood; some risk factors have been identified, but they are not enough to justify all the cases observed. Furthermore, several studies have shown that also ocular disorders present characteristics of neurodegenerative diseases and, on the other hand, CNS pathologies, i.e., Alzheimer disease (AD) and Parkinson disease (PD), which are causes of morbidity and mortality worldwide, show peculiar alterations at the ocular level. The knowledge of possible correlations could help to understand the mechanisms of onset. Moreover, the underlying mechanisms of these heterogeneous disorders are still debated. This review discusses the characteristics of the ocular illnesses, focusing on the relationship between the eye and the brain. A better comprehension could help in future new therapies, thus reducing or avoiding loss of vision and improve quality of life.

The Effectiveness of Brolucizumab and Aflibercept in Patients with Neovascular Age-Related Macular Degeneration

“…Under physiological conditions, blood vessel endothelial cells are resistant to neovascular stimuli due to the balance between pro-angiogenic factors, represented by vascular endothelial growth factor (VEGF), and anti-angiogenic factors, such as pigment epithelium-derived factor (PEDF) [ 7 , 8 ].…”

Alzheimer’s Disease Seen through the Eye: Ocular Alterations and Neurodegeneration

“…It is necessary to consider the significant limitations and controversial results that we find in the majority of the current bibliography, preventing a feasible comparison between studies. For example, some ocular events related to AD are also shared by other ocular neurodegenerative pathologies, such as age-related macular degeneration (AMD) or glaucoma [ 164 ]. In fact, some risk factors and pathophysiological mechanisms, as well as aging and histopathological changes, are common features in all of these conditions.…”

Modern Approaches to Neuroprotection in Ophthalmic Neurodegenerative Diseases

“…For the Practitioner демиелинизация и необратимая гибель нейронов [1]. Офтальмологические нейродегенеративные заболевания имеют тесную связь с системными нейродегенеративными процессами и изменениями в центральной нервной системе [2,3]. Ишемия является критическим фактором всех офтальмонейродегенераций.…”